Design Therapeutics, Inc. (DSGN) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 51 transactions totaling $93.9M, demonstrating a bullish sentiment with $58.5M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 750,000 shares valued at $0.
No significant insider buying has been recorded for DSGN in the recent period.
No significant insider selling has been recorded for DSGN in the recent period.
Based on recent SEC filings, insider sentiment for DSGN is bullish with an Insider Alignment Score of 81/100 and a net flow of $58.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Design Therapeutics, Inc. (DSGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading DSGN stock, having executed 51 transactions in the past 90 days. The most active insider is Arsani William (Executive), who has made 13 transactions totaling $40.9M.
Get notified when executives and directors at DSGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Shah Pratik | Executive | Award | 750,000 | $N/A | $0 | |
| Aug 13, 2025 | William Arsani | Executive | Sale | 345,000 | $5.25 | $1.8M | Large |
| Aug 13, 2025 | William Arsani | Executive | Sale | 217,627 | $5.25 | $1.1M | Large |
| Aug 9, 2024 | William Arsani | Executive | Sale | 814,874 | $4.25 | $3.5M | Large |
| Mar 25, 2024 | A. Berger Heather | Executive | Purchase | 1,300 | $3.74 | $4.9K | |
| Mar 25, 2024 | P. Schmid John | Executive | Purchase | 17,809 | $3.74 | $66.6K | |
| Mar 22, 2024 | P. Schmid John | Executive | Purchase | 9,156 | $3.62 | $33.1K | |
| Sep 29, 2023 | W. Lappe Rodney | Executive | Purchase | 21,000 | $2.35 | $49.4K | |
| Aug 29, 2023 | William Arsani | Executive | Purchase | 1,960,000 | $2.44 | $4.8M | Large |
| Aug 29, 2023 | Prasad Deepa | Executive | Purchase | 12,000 | $2.31 | $27.7K | |
| Aug 28, 2023 | William Arsani | Executive | Purchase | 275,000 | $2.15 | $591.3K | Large |
| Dec 20, 2022 | Capital Partners I, Lp One Sr | Executive | Purchase | 40,000 | $8.14 | $325.6K | |
| Dec 20, 2022 | George Simeon | Executive | Purchase | 40,000 | $8.14 | $325.6K | |
| Dec 20, 2022 | Siffert Joao Md | Executive | Purchase | 6,300 | $8.38 | $52.8K | |
| Dec 19, 2022 | Capital Partners I, Lp One Sr | Executive | Purchase | 360,000 | $8.63 | $3.1M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 28 | $76.2M | 81.2% |
Sale(S) | 7 | $17.7M | 18.8% |
Award(A) | 1 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 14 | $0 | 0.0% |
Insiders at Design Therapeutics, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 51 transactions totaling $76.2M in purchases versus $17.7M in sales, the net buying activity of $58.5M signals strong executive confidence. Arsani William (Executive) leads the buying activity with $40.9M in transactions across all time.